# US 2015/0104874 A1 · AKT Ligands and Polynucleotides Encoding AKT Ligands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104874 A1
- Document ID: US20150104874A1
- Status: Published application
- Kind: A1
- Application number: 14/335,550
- Filed: 2014-07-18
- Published: 2015-04-16
- Earliest claimed: 2006-06-05
- Assignees: Intrexon Corporation
- Applicants: Intrexon Corporation
- Inventors: Thomas D. REED
- Web page: https://patentgrep.com/patent/US20150104874A1

## CPC

- C07K 14/47: from mammals
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K 14/435: from animals; from humans
- C12N 15/62: DNA sequences coding for fusion proteins
- C07K 2319/01: containing a localisation/targetting motif
- C07K 2319/41: containing a Myc-tag
- C07K 2319/43: containing a FLAG-tag
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate AKT activity. The ligands, homopolyligands, and heteropolyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands, homopolyligands, and heteropolyligands.

## Claims

### Claim at position 1

1-151. (canceled)

### Claim 152

An isolated polynucleotide comprising a polynucleotide sequence encoding a polypeptide heteropolyligand comprising two or more polypeptides that are
(a) at least 90% identical to SEQ ID NO: 90, 101, 102, 194, 195, 199, 200 and 204,
(b) SEQ ID NO: 174, or
(c) SEQ ID NO: 175,
wherein Xaa is any amino acid.

### Claim 153 (depends on 152)

The isolated polynucleotide of claim 152, wherein at least one amino acid designated as Xaa is an amino acid other than serine or threonine.

### Claim 154 (depends on 152)

The isolated polynucleotide of claim 152, wherein said polypeptide heteropolyligand is linked to one or more of a localization signal, an epitope tag, or a reporter.

### Claim 155 (depends on 152)

A vector comprising the isolated polynucleotide of claim 152.

### Claim 156 (depends on 155)

A host cell comprising the vector of claim 155.

### Claim 157 (depends on 152)

The isolated polynucleotide of claim 152, operably linked to a promoter.

### Claim 158 (depends on 157)

The isolated polynucleotide of claim 157, wherein said promoter is an inducible promoter.

### Claim 159 (depends on 152)

The isolated polynucleotide of claim 152, wherein said two or more polypeptides are at least 95% identical to polypeptides selected from the group consisting of SEQ ID NOS: 90, 101, 102, 194, 195, 199, 200 and 204.

### Claim 160 (depends on 152)

The isolated polynucleotide of claim 152, wherein said two or more polypeptides are at least 96% identical to polypeptides selected from the group consisting of SEQ ID NOS: 90, 101, 102, 194, 195, 199, 200 and 204.

### Claim 161 (depends on 152)

The isolated polynucleotide of claim 152, wherein said two or more polypeptides are at least 97% identical to polypeptides selected from the group consisting of SEQ ID NOS: 90, 101, 102, 194, 195, 199, 200 and 204.

### Claim 162 (depends on 152)

The isolated polynucleotide of claim 152, wherein said two or more polypeptides are at least 98% identical to polypeptides selected from the group consisting of SEQ ID NOS: 90, 101, 102, 194, 195, 199, 200 and 204.

### Claim 163 (depends on 152)

The isolated polynucleotide of claim 152, wherein said two or more polypeptides are at least 99% identical to polypeptides selected from the group consisting of SEQ ID NOS: 90, 101, 102, 194, 195, 199, 200 and 204.

### Claim 164 (depends on 152)

The isolated polynucleotide of claim 152, wherein said two or more polypeptides are selected from the group consisting of SEQ ID NOS: 90, 101, 102, 174, 175, 194, 195, 199, 200 and 204.

### Claim 165 (depends on 155)

A method of inhibiting AKT in a cell, said method comprising
(a) transfecting the vector of claim 155 into a host cell, and
(b) culturing the transfected host cell under conditions suitable to produce at least one copy of the polypeptide polyligand.

### Claim 166 (depends on 152)

The isolated polynucleotide of claim 152, wherein the polypeptide heteropolyligand inhibits the kinase activity of mammalian protein kinase B (AKT)
